At Refine by Tulsi, we often integrate NAD+ with: Peptide Therapy Synergistic protocols for energy, recovery, and cognitive function Hormone Optimization Especially for women experiencing perimenopause or menopause-related energy decline IV Vitamin Therapy Combine NAD+ with targeted micronutrients for enhanced cellular function Metabolic Support Including GLP-1 therapy for weight management and insulin sensitivity NAD+ in Refine Her Memberships Our Refine Her Thrive Tier includes monthly NAD+ IV or at-home injection kits as part of comprehensive womens wellness care
no aspiration) CDC (Subcut Injection PDF) Technique diagram and site guidance for subcutaneous injections Additional Research and Background These sources provide related context and are not presented as support for a specific statement above
Legal and regulatory status remains restrictive in many regions, where BPC-157 is not approved for clinical use and is typically limited to research contexts
Schedule: Weekly subcutaneous injections for 1248 weeks (clinical trials ranged 3648 weeks) [2]
For systemic or musculoskeletal targets, injectable has a pharmacokinetic advantage
It may also support the gut-brain axis by influencing neurochemical pathways and promoting communication between the gastrointestinal tract and central nervous system (CNS)